FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology and deals with method of treatment in case of urinary bladder cancer. Combined treatment with application of neoadjuvant system polychemical therapy by the following scheme: 1 day -5-fluoruracyl, 2 day - cyclophosphane+vinblastine, 14 day - methotrexate, 15 day - doxorubicin, 16 day -cisplatin, and adjuvant intrabladder chemical therapy with preparation doxorubicin during 2 years, on the first day after operation doxorubicin 40 mg is instilled, then 4 instillations of doxorubicin in dose 40 mg with 7 day interval, then doxorubicin 40 mg is instilled with 30 day interval during 11 months, after that during the second year instillations of doxorubicin in dose 20 mg are performed after 1 month.
EFFECT: invention ensures improvement of results of organ-preserving treatment by reduction of number of urinary bladder cancer recurrences.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF POSTOPERATIVE THERAPY OF NON-MUSCLE INVASIVE BLADDER CANCER | 2009 |
|
RU2443423C2 |
| METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF MUSCULO-INVASIVE BLADDER CANCER FOLLOWING COMBINATION THERAPY | 2012 |
|
RU2538632C2 |
| METHOD OF PREDICTING DISTANT RESULTS OF URINARY BLADDER CANCER TREATMENT | 2010 |
|
RU2456926C2 |
| INTRAVESICAL THERAPY FOR BLADDER CANCER | 2016 |
|
RU2779543C2 |
| METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
| METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
| METHOD FOR TREATING COMPLICATED FORMS OF URINARY BLADDER CANCER | 2003 |
|
RU2257856C1 |
| METHOD OF CHEMOTHERAPY AT BLADDER CANCER | 2007 |
|
RU2352340C1 |
| METHOD FOR TREATING THE CASES OF URINARY BLADDER CANCER | 2005 |
|
RU2276605C1 |
